Your browser doesn't support javascript.
loading
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Goddard, Kristin; Lewis, Ned; Fireman, Bruce; Weintraub, Eric; Shimabukuro, Tom; Zerbo, Ousseny; Boyce, Thomas G; Oster, Matthew E; Hanson, Kayla E; Donahue, James G; Ross, Pat; Naleway, Allison; Nelson, Jennifer C; Lewin, Bruno; Glanz, Jason M; Williams, Joshua T B; Kharbanda, Elyse O; Katherine Yih, W; Klein, Nicola P.
Afiliación
  • Goddard K; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States.
  • Lewis N; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States.
  • Fireman B; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States.
  • Weintraub E; Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Shimabukuro T; Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Zerbo O; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States.
  • Boyce TG; Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Oster ME; Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States; Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States.
  • Hanson KE; Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Donahue JG; Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Ross P; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States.
  • Naleway A; Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.
  • Nelson JC; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
  • Lewin B; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
  • Glanz JM; Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, United States.
  • Williams JTB; Ambulatory Care Services, Denver Health & Hospital Authority, Denver, CO, United States.
  • Kharbanda EO; HealthPartners Institute, Minneapolis, MN, United States.
  • Katherine Yih W; Harvard Pilgrim Health Care Institute, Boston, MA, United States.
  • Klein NP; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States. Electronic address: Nicola.Klein@kp.org.
Vaccine ; 40(35): 5153-5159, 2022 08 19.
Article en En | MEDLINE | ID: mdl-35902278
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pericarditis / COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Miocarditis Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pericarditis / COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Miocarditis Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos